174 related articles for article (PubMed ID: 29936575)
1. Chronic low dose ethanol induces an aggressive metastatic phenotype in TRAMP mice, which is counteracted by parthenolide.
Morel KL; Ormsby RJ; Solly EL; Tran LNK; Sweeney CJ; Klebe S; Cordes N; Sykes PJ
Clin Exp Metastasis; 2018 Oct; 35(7):649-661. PubMed ID: 29936575
[TBL] [Abstract][Full Text] [Related]
2. Parthenolide Selectively Sensitizes Prostate Tumor Tissue to Radiotherapy while Protecting Healthy Tissues In Vivo.
Morel KL; Ormsby RJ; Bezak E; Sweeney CJ; Sykes PJ
Radiat Res; 2017 May; 187(5):501-512. PubMed ID: 28398879
[TBL] [Abstract][Full Text] [Related]
3. DMAPT is an Effective Radioprotector from Long-Term Radiation-Induced Damage to Normal Mouse Tissues
Morel KL; Ormsby RJ; Klebe S; Sweeney CJ; Sykes PJ
Radiat Res; 2019 Aug; 192(2):231-239. PubMed ID: 31095445
[TBL] [Abstract][Full Text] [Related]
4. DMAPT inhibits NF-κB activity and increases sensitivity of prostate cancer cells to X-rays in vitro and in tumor xenografts in vivo.
Mendonca MS; Turchan WT; Alpuche ME; Watson CN; Estabrook NC; Chin-Sinex H; Shapiro JB; Imasuen-Williams IE; Rangel G; Gilley DP; Huda N; Crooks PA; Shapiro RH
Free Radic Biol Med; 2017 Nov; 112():318-326. PubMed ID: 28782644
[TBL] [Abstract][Full Text] [Related]
5. Capsaicin reduces the metastatic burden in the transgenic adenocarcinoma of the mouse prostate model.
Venier NA; Yamamoto T; Sugar LM; Adomat H; Fleshner NE; Klotz LH; Venkateswaran V
Prostate; 2015 Sep; 75(12):1300-11. PubMed ID: 26047020
[TBL] [Abstract][Full Text] [Related]
6. E-7869 (R-flurbiprofen) inhibits progression of prostate cancer in the TRAMP mouse.
Wechter WJ; Leipold DD; Murray ED; Quiggle D; McCracken JD; Barrios RS; Greenberg NM
Cancer Res; 2000 Apr; 60(8):2203-8. PubMed ID: 10786685
[TBL] [Abstract][Full Text] [Related]
7. The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model.
Kaplan PJ; Mohan S; Cohen P; Foster BA; Greenberg NM
Cancer Res; 1999 May; 59(9):2203-9. PubMed ID: 10232609
[TBL] [Abstract][Full Text] [Related]
8. Early growth inhibition is followed by increased metastatic disease with vitamin D (calcitriol) treatment in the TRAMP model of prostate cancer.
Ajibade AA; Kirk JS; Karasik E; Gillard B; Moser MT; Johnson CS; Trump DL; Foster BA
PLoS One; 2014; 9(2):e89555. PubMed ID: 24586868
[TBL] [Abstract][Full Text] [Related]
9. Expression pattern of mouse homolog of prostate-specific membrane antigen (FOLH1) in the transgenic adenocarcinoma of the mouse prostate model.
Schmittgen TD; Zakrajsek BA; Hill RE; Liu Q; Reeves JJ; Axford PD; Singer MJ; Reed MW
Prostate; 2003 Jun; 55(4):308-16. PubMed ID: 12712410
[TBL] [Abstract][Full Text] [Related]
10. Raf kinase inhibitor protein (RKIP) deficiency decreases latency of tumorigenesis and increases metastasis in a murine genetic model of prostate cancer.
Escara-Wilke J; Keller JM; Ignatoski KM; Dai J; Shelley G; Mizokami A; Zhang J; Yeung ML; Yeung KC; Keller ET
Prostate; 2015 Feb; 75(3):292-302. PubMed ID: 25327941
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of MUC18 correlates with the metastatic progression of mouse prostate adenocarcinoma in the TRAMP model.
Wu GJ; Fu P; Chiang CF; Huss WJ; Greenberg NM; Wu MW
J Urol; 2005 May; 173(5):1778-83. PubMed ID: 15821586
[TBL] [Abstract][Full Text] [Related]
12. Parthenolide generates reactive oxygen species and autophagy in MDA-MB231 cells. A soluble parthenolide analogue inhibits tumour growth and metastasis in a xenograft model of breast cancer.
D'Anneo A; Carlisi D; Lauricella M; Puleio R; Martinez R; Di Bella S; Di Marco P; Emanuele S; Di Fiore R; Guercio A; Vento R; Tesoriere G
Cell Death Dis; 2013 Oct; 4(10):e891. PubMed ID: 24176849
[TBL] [Abstract][Full Text] [Related]
13. Constitutive activation of P I3 K-Akt and NF-kappaB during prostate cancer progression in autochthonous transgenic mouse model.
Shukla S; Maclennan GT; Marengo SR; Resnick MI; Gupta S
Prostate; 2005 Aug; 64(3):224-39. PubMed ID: 15712212
[TBL] [Abstract][Full Text] [Related]
14. Synthetic triterpenoid CDDO prevents the progression and metastasis of prostate cancer in TRAMP mice by inhibiting survival signaling.
Deeb D; Gao X; Liu Y; Jiang D; Divine GW; Arbab AS; Dulchavsky SA; Gautam SC
Carcinogenesis; 2011 May; 32(5):757-64. PubMed ID: 21325633
[TBL] [Abstract][Full Text] [Related]
15. A water-soluble parthenolide analogue suppresses in vivo prostate cancer growth by targeting NFkappaB and generating reactive oxygen species.
Shanmugam R; Kusumanchi P; Cheng L; Crooks P; Neelakantan S; Matthews W; Nakshatri H; Sweeney CJ
Prostate; 2010 Jul; 70(10):1074-86. PubMed ID: 20209491
[TBL] [Abstract][Full Text] [Related]
16. Safety and chemopreventive effect of Polyphenon E in preventing early and metastatic progression of prostate cancer in TRAMP mice.
Kim SJ; Amankwah E; Connors S; Park HY; Rincon M; Cornnell H; Chornokur G; Hashim AI; Choi J; Tsai YY; Engelman RW; Kumar N; Park JY
Cancer Prev Res (Phila); 2014 Apr; 7(4):435-44. PubMed ID: 24501325
[TBL] [Abstract][Full Text] [Related]
17. Loss of MyD88 leads to more aggressive TRAMP prostate cancer and influences tumor infiltrating lymphocytes.
Peek EM; Song W; Zhang H; Huang J; Chin AI
Prostate; 2015 Apr; 75(5):463-73. PubMed ID: 25597486
[TBL] [Abstract][Full Text] [Related]
18. Androgen-independent prostate cancer progression in the TRAMP model.
Gingrich JR; Barrios RJ; Kattan MW; Nahm HS; Finegold MJ; Greenberg NM
Cancer Res; 1997 Nov; 57(21):4687-91. PubMed ID: 9354422
[TBL] [Abstract][Full Text] [Related]
19. Differential requirement for Src family tyrosine kinases in the initiation, progression, and metastasis of prostate cancer.
Gelman IH; Peresie J; Eng KH; Foster BA
Mol Cancer Res; 2014 Oct; 12(10):1470-9. PubMed ID: 25053806
[TBL] [Abstract][Full Text] [Related]
20. Phellodendron amurense bark extract prevents progression of prostate tumors in transgenic adenocarcinoma of mouse prostate: potential for prostate cancer management.
Ghosh R; Graham H; Rivas P; Tan XJ; Crosby K; Bhaskaran S; Schoolfield J; Banu J; Fernandes G; Yeh IT; Kumar AP
Anticancer Res; 2010 Mar; 30(3):857-65. PubMed ID: 20393007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
